checkAd
    Startseite > Aktien > Surmodics > Nachrichten
    Surmodics Aktie
    34,08
     
    USD
    +1,55 %
    +0,52 USD
    Letzter Kurs 02:00:00 Nasdaq
    34,07
     
    USD
    100 STK
    Geldkurs 16.05.24
    34,20
     
    USD
    1.000 STK
    Briefkurs 16.05.24
    ISIN: US8688731004 · WKN: 914178 · SYM: SRDX · USA

    Neueste Nachrichten

    Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
    01.05.24 · Business Wire (engl.) · Surmodics
    Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
    19.04.24 · Business Wire (engl.) · Surmodics
    Surmodics to Participate in Upcoming Investor Conferences in March and April
    27.02.24 · Business Wire (engl.) · Surmodics
    Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
    01.02.24 · Business Wire (engl.) · Surmodics
    Surmodics Announces Successful Early Clinical Use of Pounce LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee
    22.01.24 · Business Wire (engl.) · Surmodics
    Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
    16.01.24 · Business Wire (engl.) · Surmodics
    Surmodics to Host Virtual Annual Meeting of Shareholders
    16.01.24 · Business Wire (engl.) · Surmodics
    Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium
    16.11.23 · Business Wire (engl.) · Surmodics
    Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
    16.11.23 · Business Wire (engl.) · Surmodics
    Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28
    14.11.23 · Business Wire (engl.) · Surmodics
    Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance
    08.11.23 · Business Wire (engl.) · Surmodics
    Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium
    07.11.23 · Business Wire (engl.) · Surmodics